Sharda Cropchem cash flow

Latest FY26

Cash from operations: ₹656cr+8.6% on FY25
Capital spending: ₹497cr+26.5% on FY25
Free cash flow: ₹158cr−24.8% on FY25
Cash from financing: −₹118cr−₹67.9 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	325	275	267	248
	—	37.5	68.1	34.9	0.0
	—	1.8	2.1	3.6	4.5
	—	−39.2	−27.6	−13.6	−4.9
	—	11.2	−8.1	−3.8	13.7
	—	38.6	−5.9	19.4	2.3
	—	−32.3	−9.9	−34.7	18.6
	—	−22.8	0.0	0.0	0.0
	—	0.0	−6.6	−0.2	−15.8
	—	−148	19.7	143	−242
	—	−382	−456	323	−293
	—	−5.7	0.1	0.0	20.3
	—	−53.0	0.0	−0.0	−13.7
	—	−121	−23.5	3.1	20.3
	—	1.6	5.3	−1.9	0.0
	—	165	402	−424	207
	—	56.4	41.0	−0.8	0.6
	—	0.0	0.0	−8.0	21.2
	—	0.0	0.0	0.0	−24.7
	—	31.8	−18.5	13.0	0.0
Cash from operating activities
	827	856	378	71.9	431
	—	−135	256	320	−37.2
	—	721	635	392	394
	—	65.0	31.0	50.4	65.3
	—	656	604	341	328
Cash from investing activities
	—	0.5	0.2	0.5	0.7
	—	497	393	272	243
	—	0.1	0.0	0.0	0.1
	—	0.0	5.5	10.1	4.4
	—	24.3	6.1	0.0	0.0
	—	−40.1	−129	−132	94.4
	—	−513	−510	−393	−145
Cash from financing activities
	—	0.0	0.0	0.4	89.5
	—	0.0	3.4	0.0	124
	—	8.1	8.1	8.1	5.6
	—	1.4	1.2	2.2	1.4
	—	109	55.3	27.0	55.3
	—	−118	−67.9	−36.9	−97.1
	—	24.3	25.6	−89.1	86.0
	—	68.3	14.3	0.6	33.0
	—	92.6	39.9	−88.5	119
	—	—	—	87.3	176
Reference items
	1,078	1,076	596	283	643
	19.7%	20.4%	13.8%	8.9%	15.9%
	158	158	211	69.2	84.2
	—	157	206	67.4	—
	₹17.56	₹17.56	₹23.34	₹7.67	₹9.33
	38.86×	—	—	—	—
	—	0.96×	1.98×	10.70×	0.96×
	—	65.0	31.0	50.4	65.3
	—	1.4	1.2	2.2	1.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHARDACROP₹682.30

Sharda Cropchem Ltd.

· Chemicals

₹ CrorePeersUPL PIIND STYRENIX REFEX SUDARSCHEM SUDEEPPHRM RCF RALLISMcap ₹6,156 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	248.1	267.1	274.7	324.5	—
+ Impairment Loss / (Reversal)	0.0	34.9	68.1	37.5	—
+ Finance Costs	4.5	3.6	2.1	1.8	—
+ Interest Income	-4.9	-13.6	-27.6	-39.2	—
+ Fair Value (Gains) / Losses	13.7	-3.8	-8.1	11.2	—
+ Unrealised FX (Gain) / Loss	2.3	19.4	-5.9	38.6	—
+ Other Non-cash Items	18.6	-34.7	-9.9	-32.3	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	0.0	-22.8	—
+ Other Reconciling Items	-15.8	-0.2	-6.6	0.0	—
Changes in Working Capital
+ Inventories	-241.6	142.7	19.7	-147.6	—
+ Trade Receivables — Current	-293.1	322.9	-456.3	-381.7	—
+ Other Financial Assets — Current	20.3	0.0	0.1	-5.7	—
+ Other Financial Assets — Non-current	-13.7	-0.0	0.0	-53.0	—
+ Other Current Assets	20.3	3.1	-23.5	-120.6	—
+ Other Non-current Assets	0.0	-1.9	5.3	1.6	—
+ Trade Payables — Current	207.0	-424.1	401.5	164.8	—
+ Other Financial Liabilities — Current	0.6	-0.8	41.0	56.4	—
+ Other Current Liabilities	21.2	-8.0	0.0	0.0	—
+ Provisions — Current	-24.7	0.0	0.0	0.0	—
+ Provisions — Non-current	0.0	13.0	-18.5	31.8	—
Cash from Operating Activities
Profit Before Tax (per I/S)	430.7	71.9	378.3	855.5	826.6
+ Total Adjustments (incl. Working Capital)	-37.2	319.8	256.2	-134.8	—
Cash from Operations (pre-tax)	393.5	391.7	634.6	720.7	—
+ Income Taxes Paid	65.3	50.4	31.0	65.0	—
Cash from Operating Activities	328.3	341.3	603.6	655.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	0.7	0.5	0.2	0.5	—
+ Acq of Intangible Assets	243.4	271.6	392.9	496.7	—
+ Disp of Fixed Assets	0.1	0.0	0.0	0.1	—
+ Dividends Received — Investing	4.4	10.1	5.5	0.0	—
+ Interest Received — Investing	0.0	0.0	6.1	24.3	—
+ Other Inflows / (Outflows) — Investing	94.4	-131.5	-128.6	-40.1	—
Cash from Investing Activities	-145.2	-393.5	-510.1	-513.1	—
Cash from Financing Activities
+ Proceeds from Borrowings	89.5	0.4	0.0	0.0	—
+ Repayment of Borrowings	124.3	0.0	3.4	0.0	—
+ Payment of Lease Liabilities	5.6	8.1	8.1	8.1	—
+ Interest Paid	1.4	2.2	1.2	1.4	—
+ Dividends Paid	55.3	27.0	55.3	108.8	—
Cash from Financing Activities	-97.1	-36.9	-67.9	-118.3	—
Net Changes in Cash (pre-FX)	86.0	-89.1	25.6	24.3	—
+ Effect of FX Rate Changes on Cash	33.0	0.6	14.3	68.3	—
Net Changes in Cash	119.0	-88.5	39.9	92.6	—
Closing Cash	176.4	87.3	—	—	—
Reference Items
EBITDA	643.1	282.9	595.6	1,076.2	1,078.2
EBITDA Margin %	15.90	8.94	13.79	20.43	19.68
Free Cash Flow (CFO − Capex)	84.2	69.2	210.6	158.4	158.4
Free Cash Flow to Equity	—	67.4	206.0	157.0	—
Free Cash Flow per Basic Share	9.33	7.67	23.34	17.56	17.56
Price to Free Cash Flow	—	—	—	—	38.86
Cash Flow to Net Income	0.96	10.70	1.98	0.96	—
Cash Paid for Taxes	65.3	50.4	31.0	65.0	—
Cash Paid for Interest	1.4	2.2	1.2	1.4	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.